The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a natural hallucinogen, acting as a non-selective serotonin 5-HT(1A)/5-HT(2A)-R agonist. Psychotomimetic agents such as the non-competitive NMDA-R antagonist phencyclidine and serotonergic hallucinogens (DOI and 5-MeO-DMT) disrupt cortical synchrony in the low frequency range (<4 Hz) in rat prefrontal cortex (PFC), an effect reversed by antipsychotic drugs. Here we extend these observations by examining the effect of 5-MeO-DMT on low frequency cortical oscillations (LFCO, <4 Hz) in PFC, visual (V1), somatosensory (S1) and auditory (Au1) cortices, as well as the dependence of these effects on 5-HT(1A)-R and 5-HT(2A)-R, using wild type (WT) and 5-HT(2A)-R knockout (KO2A) anesthetized mice. 5-MeO-DMT reduced LFCO in the PFC of WT and KO2A mice. The effect in KO2A mice was fully prevented by the 5-HT(1A)-R antagonist WAY-100635. Systemic and local 5-MeO-DMT reduced 5-HT release in PFC mainly via 5-HT(1A)-R. Moreover, 5-MeO-DMT reduced LFCO in S1, Au1 and V1 of WT mice and only in V1 of KO2A mice, suggesting the involvement of 5-HT(1A)-R activation in the 5-MeO-DMT-induced disruption of V1 activity. In addition, antipsychotic drugs reversed 5-MeO-DMT effects in WT mice. The present results suggest that the hallucinogen action of 5-MeO-DMT is mediated by simultaneous alterations of the activity of sensory (S1, Au1, V1) and associative (PFC) cortical areas, also supporting a role of 5-HT(1A)-R stimulation in V1 and PFC, in addition to the well-known action on 5-HT(2A)-R. Moreover, the reversal by antipsychotic drugs of 5-MeO-DMT effects adds to previous literature supporting the usefulness of the present model in antipsychotic drug development.

[1]  J. Palacios,et al.  Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors , 1987, Neuroscience.

[2]  Andreas Bäbler,et al.  Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action , 1998, Neuroreport.

[3]  Felix Hasler,et al.  Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans , 2007, Psychopharmacology.

[4]  A. Frazer,et al.  Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. , 1984, The Journal of pharmacology and experimental therapeutics.

[5]  M. Hajós,et al.  Role of the medial prefrontal cortex in 5‐HT1A receptor‐induced inhibition of 5‐HT neuronal activity in the rat , 1999, British journal of pharmacology.

[6]  S. Peroutka,et al.  Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  P. Celada,et al.  The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs , 2008, Biological Psychiatry.

[8]  M. Geyer,et al.  The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats , 2006, Psychopharmacology.

[9]  D. Rhie,et al.  Serotonin inhibits the induction of NMDA receptor-dependent long-term potentiation in the rat primary visual cortex , 2006, Brain Research.

[10]  Sidarta Ribeiro,et al.  Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion , 2012, Human brain mapping.

[11]  M. Cynader,et al.  Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: transient regional, laminar, and columnar distributions during postnatal development , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  P. Celada,et al.  Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors , 2001, The Journal of Neuroscience.

[13]  D. Rhie,et al.  Differential modulation of phasic and tonic inhibition underlies serotonergic suppression of long-term potentiation in the rat visual cortex , 2015, Neuroscience.

[14]  P. Celada,et al.  Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei , 2002, Brain Research Reviews.

[15]  R. Hen,et al.  5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice , 2002 .

[16]  A. Gogos,et al.  Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology , 2008, Behavioural pharmacology.

[17]  F. Artigas,et al.  Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors , 2008, Cerebral cortex.

[18]  P. Celada,et al.  5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. , 2012, Cerebral cortex.

[19]  R. A. O'connell,et al.  Treatment of Mood Disorders with Lithium Carbonate , 1970 .

[20]  Anthony A. Grace,et al.  Alterations in Medial Prefrontal Cortical Activity and Plasticity in Rats with Disruption of Cortical Development , 2006, Biological Psychiatry.

[21]  Kuei Yuan Tseng,et al.  D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex , 2007, Synapse.

[22]  J. C. Winter,et al.  The Paradox of 5-Methoxy-N,N-Dimethyltryptamine An Indoleamine Hallucinogen That Induces Stimulus Control Via 5-HT1A Receptors , 2000, Pharmacology Biochemistry and Behavior.

[23]  W. Singer,et al.  Abnormal neural oscillations and synchrony in schizophrenia , 2010, Nature Reviews Neuroscience.

[24]  G. Mengod,et al.  Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2004, Cerebral cortex.

[25]  F. Vollenweider,et al.  The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations , 2011, Biological Psychiatry.

[26]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[27]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[28]  P. Celada,et al.  Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist , 2006, European Neuropsychopharmacology.

[29]  P. Celada,et al.  Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. , 2004, Cerebral cortex.

[30]  L. Maffei,et al.  Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats , 2011, The European journal of neuroscience.

[31]  Paul Leonard Gabbott,et al.  Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers , 2005, The Journal of comparative neurology.

[32]  J. C. Winter,et al.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. , 2010, Current drug metabolism.

[33]  P. Celada,et al.  Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action. , 2013, The international journal of neuropsychopharmacology.

[34]  P S Goldman-Rakic,et al.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Celada,et al.  Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine , 2007, Proceedings of the National Academy of Sciences.

[36]  G. Aghajanian,et al.  Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release , 1999, Brain Research.

[37]  B. Roth,et al.  Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism , 2001, The Journal of Neuroscience.

[38]  Kuei Yuan Tseng,et al.  D 2 Dopamine Receptors Recruit a GABA Component for Their Attenuation of Excitatory Synaptic Transmission in the Adult Rat Prefrontal Cortex , 2007 .

[39]  Adrian Preda,et al.  Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. , 2015, Schizophrenia bulletin.

[40]  V. Risbrough,et al.  Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia , 2011, Neuropharmacology.

[41]  G. Mengod,et al.  Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2009, Cerebral cortex.

[42]  G. Aghajanian,et al.  Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin , 1977, Neuropharmacology.

[43]  A. Bortolozzi,et al.  Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. , 2010, The international journal of neuropsychopharmacology.

[44]  A. Newman-Tancredi,et al.  Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties , 2011, Psychopharmacology.

[45]  J. Leysen,et al.  Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography , 1993, Brain Research.

[46]  G. Buzsáki,et al.  Neuronal Oscillations in Cortical Networks , 2004, Science.

[47]  M. Geyer,et al.  Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice , 2011, Journal of psychopharmacology.

[48]  M. Geyer,et al.  8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action , 2005, Psychopharmacology.

[49]  Stuart C. Sealfon,et al.  Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.

[50]  S. Houle,et al.  Serotonin 2A receptors and visual hallucinations in Parkinson disease. , 2010, Archives of neurology.

[51]  R. Andrade,et al.  Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex , 2007, Proceedings of the National Academy of Sciences.

[52]  Adam L. Halberstadt,et al.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens , 2011, Neuropharmacology.

[53]  P. Celada,et al.  The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. , 2014, The international journal of neuropsychopharmacology.

[54]  Jordi Serrats,et al.  Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2004, Cerebral cortex.

[55]  Karl J. Friston,et al.  Broadband Cortical Desynchronization Underlies the Human Psychedelic State , 2013, The Journal of Neuroscience.

[56]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[57]  P. Celada,et al.  Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT1A Receptor-Dependent Mechanism , 2012, Neuropsychopharmacology.

[58]  P. Anderer,et al.  Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. , 2002, British journal of clinical pharmacology.

[59]  P. Celada,et al.  Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. , 2004, Cerebral cortex.